Sign in

CIK 0001070081

  • Large accelerated filer

PTC THERAPEUTICS, INC.

Sign in to watch
Ticker
PTCT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043416587
Phone
+1 908-222-7000
Business address
500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
Former names
PTC THERAPEUTICS INC
  1. 4 Grant or award CHIEF TECHNICAL OPS OFFICER acquired 18,020 shares (grant or award)
  2. 4 Grant or award SVP, CHIEF ACCOUNTING OFFICER acquired 13,250 shares (grant or award)
  3. 4 Grant or award EVP & CHIEF MEDICAL OFFICER acquired 18,750 shares (grant or award)
  4. 4 Grant or award CHIEF BUSINESS OFFICER acquired 20,000 shares (grant or award)
  5. 4 Planned sale EXEC. VP AND CLO sold 2,266 shares at an average $75.55 ($171,192)
  6. 4 Planned sale Director sold 734 shares at $76.00 ($55,784)
  7. 4 Grant or award Director acquired 4,000 shares (grant or award)
  8. 4 Grant or award Director acquired 4,000 shares (grant or award)
  9. 4 Grant or award Director acquired 4,000 shares (grant or award)
  10. 4 Grant or award Director acquired 4,000 shares (grant or award)
  11. 4 Grant or award Director acquired 4,000 shares (grant or award)
  12. 4 Grant or award Director acquired 8,000 shares (grant or award)
  13. 4 Grant or award CHIEF FINANCIAL OFFICER acquired 20,000 shares (grant or award)
  14. 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 63,000 shares (grant or award)
  15. 4 Planned sale Director sold 12,000 shares at $76.35 ($916,200)
  16. 4 Planned sale CHIEF EXECUTIVE OFFICER sold 8,089 shares at $76.64 ($619,941)
  17. 4 Planned sale CHIEF BUSINESS OFFICER sold 20,508 shares at an average $77.26 ($1,584,350)
  18. 4 Planned sale CHIEF BUSINESS OFFICER sold 43,492 shares at an average $75.40 ($3,279,275)
  19. 4 Exercise or conversion Director acquired 24,000 shares (option exercise)
  20. 4 Planned sale Director sold 733 shares at $78.62 ($57,628)

Page 4 of 31 · 617 filings